Expression of RPS4X in endometrial cancer

UTERINE CORPUS ENDOMETRIAL CARCINOMA (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS4X is not prognostic in Uterine Corpus Endometrial Carcinoma (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1628.05

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

5-year survival highⁱ N/A

5-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

1268.8

Number of samples

176

Samples

Sample	Description	TPM
TCGA-E6-A8L9-01A	61 years, female, black or african american, stage:Stage IB, alive, 1013 days	3682.2
TCGA-EY-A72D-01A	87 years, female, black or african american, stage:Stage II, alive, 179 days	3131.0
TCGA-EY-A210-01A	82 years, female, black or african american, stage:Stage IIIC, alive, 383 days	2852.5
TCGA-AX-A3FW-01A	66 years, female, white, stage:Stage IB, alive, 17 days	2665.8
TCGA-BK-A13B-01A	58 years, female, black or african american, stage:Stage IB, alive, 966 days	2660.2
TCGA-AX-A1C7-01A	77 years, female, white, stage:Stage IB, alive, 1054 days	2625.0
TCGA-B5-A3F9-01A	56 years, female, black or african american, stage:Stage IB, alive, 4155 days	2605.6
TCGA-EY-A547-01A	75 years, female, black or african american, stage:Stage IA, alive, 545 days	2595.3
TCGA-EY-A548-01A	83 years, female, black or african american, stage:Stage IA, alive, 430 days	2505.6
TCGA-EO-A22Y-01A	68 years, female, white, stage:Stage IA, alive, 1567 days	2452.5
TCGA-BS-A0V4-01A	56 years, female, white, stage:Stage IB, alive, 1810 days	2437.3
TCGA-DI-A2QT-01A	51 years, female, american indian or alaska native, stage:Stage IIIC, dead, 377 days	2410.1
TCGA-PG-A7D5-01A	62 years, female, black or african american, stage:Stage IA, alive, 1177 days	2401.9
TCGA-EO-A22X-01A	36 years, female, stage:Stage IIIA, alive, 1752 days	2375.1
TCGA-PG-A917-01A	74 years, female, black or african american, stage:Stage IA, alive, 212 days	2355.0
TCGA-EY-A5W2-01A	72 years, female, black or african american, stage:Stage IB, alive, 516 days	2311.9
TCGA-AJ-A3BG-01A	65 years, female, white, stage:Stage IA, alive, 550 days	2288.1
TCGA-A5-A1OH-01A	86 years, female, white, stage:Stage IIIA, alive, 1105 days	2287.0
TCGA-K6-A3WQ-01A	60 years, female, white, stage:Stage IVB, dead, 427 days	2268.3
TCGA-E6-A2P8-01A	53 years, female, black or african american, stage:Stage IV, dead, 72 days	2246.2
TCGA-B5-A3S1-01A	71 years, female, white, stage:Stage IIIC, alive, 902 days	2203.9
TCGA-QF-A5YT-01A	57 years, female, black or african american, stage:Stage II, alive, 1215 days	2203.3
TCGA-PG-A5BC-01A	72 years, female, black or african american, stage:Stage II, alive, 707 days	2200.8
TCGA-B5-A5OE-01A	68 years, female, black or african american, stage:Stage IIIC, alive, 1063 days	2155.7
TCGA-QF-A5YS-01A	57 years, female, black or african american, stage:Stage II, alive, 689 days	2129.6
TCGA-A5-AB3J-01A	52 years, female, black or african american, stage:Stage II, alive, 512 days	2113.7
TCGA-DF-A2KV-01A	55 years, female, stage:Stage IB, alive, 2717 days	2051.5
TCGA-PG-A6IB-01A	68 years, female, black or african american, stage:Stage IA, alive, 648 days	2040.1
TCGA-PG-A916-01A	70 years, female, black or african american, stage:Stage I, alive, 522 days	2013.0
TCGA-DF-A2KY-01A	49 years, female, stage:Stage IVA, alive, 332 days	1962.4
TCGA-B5-A3FB-01A	73 years, female, black or african american, stage:Stage IB, alive, 2844 days	1949.7
TCGA-AJ-A3EK-01A	53 years, female, white, stage:Stage IA, alive, 446 days	1885.8
TCGA-DF-A2KU-01A	female, stage:Stage IB, alive, 3067 days	1877.3
TCGA-EO-A22U-01A	83 years, female, white, stage:Stage IB, alive, 1407 days	1871.3
TCGA-AJ-A3NF-01A	60 years, female, white, stage:Stage IIIC, alive, 645 days	1859.7
TCGA-AJ-A3QS-01A	57 years, female, black or african american, stage:Stage IIIA, alive, 513 days	1829.7
TCGA-EY-A2OQ-01A	61 years, female, white, stage:Stage IA, alive, 885 days	1796.6
TCGA-AJ-A3NE-01A	46 years, female, white, stage:Stage IA, alive, 628 days	1770.6
TCGA-AJ-A3EL-01A	47 years, female, native hawaiian or other pacific islander, stage:Stage IA, alive, 684 days	1769.8
TCGA-B5-A3FD-01A	70 years, female, black or african american, stage:Stage IA, dead, 1197 days	1762.9
TCGA-2E-A9G8-01A	59 years, female, black or african american, stage:Stage III, alive, 1249 days	1761.5
TCGA-PG-A915-01A	60 years, female, black or african american, stage:Stage IA, alive, 249 days	1752.3
TCGA-EY-A3L3-01A	82 years, female, black or african american, stage:Stage IA, alive, 832 days	1735.8
TCGA-AX-A3G8-01A	76 years, female, white, stage:Stage IA, alive, 36 days	1727.6
TCGA-DI-A1C3-01A	38 years, female, white, stage:Stage IB, alive, 739 days	1719.4
TCGA-AX-A3FT-01A	64 years, female, white, stage:Stage IB, alive, 6 days	1705.7
TCGA-BK-A4ZD-01A	42 years, female, black or african american, stage:Stage IA, alive, 506 days	1705.2
TCGA-EO-A3B0-01A	43 years, female, asian, stage:Stage IIIC, alive, 1412 days	1705.1
TCGA-AJ-A5DW-01A	56 years, female, black or african american, stage:Stage IA, alive, 390 days	1682.0
TCGA-AJ-A5DV-01A	65 years, female, black or african american, stage:Stage IA, alive, 679 days	1677.0
TCGA-AJ-A3BF-01A	65 years, female, white, stage:Stage IIIC, alive, 551 days	1669.6
TCGA-EO-A3KX-01A	80 years, female, white, stage:Stage IA, alive, 1170 days	1653.6
TCGA-D1-A3DG-01A	81 years, female, white, stage:Stage IVB, dead, 130 days	1621.2
TCGA-AJ-A3BK-01A	68 years, female, white, stage:Stage IC, alive, 1031 days	1616.2
TCGA-JU-AAVI-01A	61 years, female, black or african american, stage:Stage IIIC, dead, 540 days	1589.8
TCGA-QS-A5YR-01A	61 years, female, black or african american, stage:Stage IIIB, alive, 719 days	1589.8
TCGA-B5-A3FC-01A	53 years, female, black or african american, stage:Stage II, alive, 2185 days	1586.1
TCGA-AX-A2H4-01A	66 years, female, white, stage:Stage IIIA, dead, 916 days	1537.5
TCGA-DI-A1BU-01A	55 years, female, white, stage:Stage IIB, alive, 1195 days	1504.3
TCGA-4E-A92E-01A	54 years, female, black or african american, stage:Stage I, alive, 13 days	1495.5
TCGA-A5-A2K5-01A	76 years, female, white, stage:Stage IA, alive, 752 days	1470.1
TCGA-DF-A2L0-01A	60 years, female, stage:Stage IIIC, dead, 788 days	1463.7
TCGA-PG-A914-01A	73 years, female, black or african american, stage:Stage IA, alive, 687 days	1381.3
TCGA-AJ-A6NU-01A	64 years, female, black or african american, stage:Stage II, alive, 632 days	1377.8
TCGA-BK-A6W3-01A	34 years, female, black or african american, stage:Stage II, alive, 305 days	1366.4
TCGA-B5-A1MW-01A	55 years, female, white, stage:Stage IA, alive, 447 days	1365.4
TCGA-EY-A1GL-01A	51 years, female, white, stage:Stage II, alive, 1014 days	1362.0
TCGA-EY-A1GX-01A	76 years, female, white, stage:Stage IIIA, dead, 1127 days	1353.9
TCGA-EY-A4KR-01A	56 years, female, black or african american, stage:Stage IIIC, dead, 346 days	1335.6
TCGA-DF-A2KR-01A	84 years, female, stage:Stage IIIC, alive, 1865 days	1330.0
TCGA-A5-A7WJ-01A	64 years, female, black or african american, stage:Stage IA, alive, 341 days	1324.7
TCGA-AX-A2IN-01A	63 years, female, white, stage:Stage IC, dead, 947 days	1320.3
TCGA-AJ-A3OJ-01A	54 years, female, white, stage:Stage II, alive, 467 days	1306.6
TCGA-B5-A5OC-01A	71 years, female, black or african american, stage:Stage IIIB, alive, 1249 days	1300.1
TCGA-BK-A0CA-01A	61 years, female, white, stage:Stage IIIC, alive, 1064 days	1297.4
TCGA-AX-A3FS-01A	82 years, female, white, stage:Stage IA, alive, 7 days	1296.4
TCGA-DF-A2KZ-01A	87 years, female, stage:Stage IB, alive, 826 days	1294.8
TCGA-EO-A3B1-01A	63 years, female, stage:Stage IB, alive, 820 days	1281.9
TCGA-EY-A2ON-01A	61 years, female, black or african american, stage:Stage IVB, dead, 610 days	1277.5
TCGA-D1-A3DA-01A	77 years, female, white, stage:Stage IIIC, alive, 483 days	1240.0
TCGA-B5-A0K9-01A	88 years, female, white, stage:Stage II, dead, 409 days	1227.9
TCGA-KP-A3VZ-01A	69 years, female, white, stage:Stage IV, alive, 722 days	1222.5
TCGA-AX-A3FZ-01A	33 years, female, white, stage:Stage IIIB, alive, 6 days	1216.6
TCGA-H5-A2HR-01A	71 years, female, black or african american, stage:Stage IB, alive, 53 days	1214.8
TCGA-D1-A3JQ-01A	61 years, female, white, stage:Stage IIIC, alive, 526 days	1207.2
TCGA-AJ-A3NH-01A	90 years, female, white, stage:Stage IB, dead, 1 days	1204.9
TCGA-EY-A54A-01A	67 years, female, black or african american, stage:Stage IIIC, alive, 447 days	1165.9
TCGA-A5-A3LP-01A	74 years, female, white, stage:Stage IB, alive, 455 days	1165.9
TCGA-AJ-A3BI-01A	67 years, female, white, stage:Stage IA, alive, 575 days	1164.4
TCGA-BK-A56F-01A	75 years, female, black or african american, stage:Stage IB, alive, 401 days	1153.8
TCGA-E6-A2P9-01A	65 years, female, white, stage:Stage IA, alive, 1386 days	1153.8
TCGA-AX-A3GB-01A	73 years, female, white, stage:Stage IB, alive, 440 days	1151.5
TCGA-B5-A0JR-01A	73 years, female, white, stage:Stage IB, alive, 1731 days	1140.6
TCGA-QS-A8F1-01A	85 years, female, black or african american, stage:Stage IIIA, dead, 135 days	1124.9
TCGA-BS-A0V7-01A	48 years, female, native hawaiian or other pacific islander, stage:Stage IB, alive, 1934 days	1116.8
TCGA-BG-A3EW-01A	62 years, female, white, stage:Stage III, alive, 344 days	1087.7
TCGA-EY-A3QX-01A	64 years, female, white, stage:Stage IVB, dead, 989 days	1086.9
TCGA-AX-A3G9-01A	63 years, female, white, stage:Stage IIIC, alive, 558 days	1073.1
TCGA-BG-A3PP-01A	82 years, female, white, stage:Stage II, alive, 681 days	1068.6
TCGA-DI-A2QY-01A	64 years, female, white, stage:Stage IIB, dead, 3349 days	1065.5
TCGA-B5-A3FH-01A	74 years, female, black or african american, stage:Stage IA, alive, 841 days	1065.1
TCGA-SJ-A6ZJ-01A	61 years, female, black or african american, stage:Stage IB, alive, 556 days	1059.4
TCGA-FI-A3PV-01A	68 years, female, black or african american, stage:Stage IA, dead, 1249 days	1033.4
TCGA-EY-A1GP-01A	54 years, female, black or african american, stage:Stage IA, alive, 573 days	1022.5
TCGA-KJ-A3U4-01A	55 years, female, white, stage:Stage IA, alive, 1095 days	984.7
TCGA-SL-A6JA-01A	77 years, female, black or african american, stage:Stage IB, alive, 7 days	983.2
TCGA-B5-A5OD-01A	67 years, female, black or african american, stage:Stage IIIC, alive, 1038 days	981.1
TCGA-EO-A3AZ-01A	80 years, female, stage:Stage IB, alive, 826 days	962.3
TCGA-A5-A2K7-01A	41 years, female, stage:Stage II, alive, 1063 days	952.8
TCGA-KP-A3W0-01A	72 years, female, stage:Stage IB, alive, 404 days	937.0
TCGA-AJ-A3OK-01A	73 years, female, white, stage:Stage IA, alive, 485 days	918.4
TCGA-QS-A5YQ-01A	55 years, female, black or african american, stage:Stage IIIA, alive, 759 days	915.3
TCGA-BK-A6W4-01A	62 years, female, black or african american, stage:Stage IA, alive, 300 days	902.8
TCGA-AX-A3G6-01A	67 years, female, white, stage:Stage IA, alive, 8 days	896.9
TCGA-DF-A2KN-01A	female, stage:Stage IC, alive, 67 days	888.5
TCGA-KP-A3W4-01A	63 years, female, white, stage:Stage IIIA, dead, 554 days	883.9
TCGA-A5-A2K4-01A	69 years, female, white, stage:Stage IIIA, dead, 871 days	872.7
TCGA-D1-A3JP-01A	61 years, female, white, stage:Stage IA, alive, 515 days	868.0
TCGA-D1-A2G0-01A	70 years, female, white, stage:Stage IB, alive, 1484 days	868.0
TCGA-AJ-A3I9-01A	52 years, female, white, stage:Stage II, dead, 519 days	867.2
TCGA-AJ-A3OL-01A	55 years, female, white, stage:Stage IIIA, dead, 449 days	861.5
TCGA-A5-A3LO-01A	64 years, female, white, stage:Stage IB, alive, 776 days	849.3
TCGA-AJ-A3TW-01A	78 years, female, white, stage:Stage IB, alive, 513 days	842.5
TCGA-AJ-A23N-01A	70 years, female, white, stage:Stage IIIA, dead, 439 days	832.7
TCGA-AJ-A8CT-01A	58 years, female, black or african american, stage:Stage IA, alive, 82 days	818.8
TCGA-AJ-A3NC-01A	63 years, female, white, stage:Stage IA, alive, 1125 days	794.0
TCGA-AX-A2HH-01A	60 years, female, white, stage:Stage IA, alive, 540 days	791.8
TCGA-B5-A11R-01A	51 years, female, black or african american, stage:Stage II, alive, 2349 days	789.0
TCGA-EY-A1GO-01A	65 years, female, white, stage:Stage IIIC, alive, 586 days	772.1
TCGA-EO-A1Y7-01A	65 years, female, stage:Stage IB, alive, 1495 days	766.0
TCGA-AJ-A2QM-01A	67 years, female, white, stage:Stage II, alive, 894 days	753.4
TCGA-AX-A3GI-01A	66 years, female, black or african american, stage:Stage IIIC, alive, 12 days	725.2
TCGA-D1-A3DH-01A	71 years, female, white, stage:Stage IA, alive, 573 days	713.2
TCGA-QS-A744-01A	86 years, female, black or african american, stage:Stage IIIB, alive, 451 days	701.3
TCGA-AX-A3G7-01A	71 years, female, white, stage:Stage IVB, alive, 9 days	680.6
TCGA-AJ-A2QO-01A	85 years, female, white, stage:Stage IB, dead, 1045 days	672.0
TCGA-AJ-A3EJ-01A	74 years, female, white, stage:Stage IIIC, dead, 50 days	663.5
TCGA-A5-A2K3-01A	68 years, female, white, stage:Stage IA, alive, 2012 days	655.8
TCGA-AJ-A3EM-01A	69 years, female, white, stage:Stage IB, alive, 677 days	653.9
TCGA-BK-A139-01A	74 years, female, white, stage:Stage IB, dead, 943 days	650.3
TCGA-EO-A3L0-01A	76 years, female, white, stage:Stage IA, alive, 1554 days	632.8
TCGA-B5-A0JN-01A	84 years, female, black or african american, stage:Stage IVB, alive, 1939 days	627.8
TCGA-AJ-A3NG-01A	83 years, female, white, stage:Stage II, alive, 475 days	605.7
TCGA-AX-A3G4-01A	60 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, alive, 9 days	559.9
TCGA-EO-A3AU-01A	72 years, female, stage:Stage II, alive, 1543 days	559.6
TCGA-AP-A5FX-01A	68 years, female, black or african american, stage:Stage IIIC, dead, 1099 days	544.7
TCGA-AX-A3G3-01A	58 years, female, white, stage:Stage IIIA, alive, 42 days	540.1
TCGA-B5-A3FA-01A	73 years, female, white, stage:Stage IC, alive, 2929 days	530.7
TCGA-EY-A549-01A	78 years, female, black or african american, stage:Stage IA, alive, 605 days	513.4
TCGA-AX-A3G1-01A	84 years, female, white, stage:Stage IC, dead, 624 days	499.7
TCGA-5B-A90C-01A	69 years, female, black or african american, stage:Stage IA, alive, 1202 days	496.2
TCGA-AJ-A8CW-01A	64 years, female, black or african american, stage:Stage IA, alive, 4 days	495.6
TCGA-EO-A3KU-01A	68 years, female, stage:Stage II, alive, 677 days	493.5
TCGA-AJ-A8CV-01A	58 years, female, black or african american, stage:Stage IB, alive, 1068 days	490.0
TCGA-5S-A9Q8-01A	51 years, female, black or african american, stage:Stage IIIA, alive, 313 days	479.5
TCGA-EY-A2OP-01A	63 years, female, white, stage:Stage IA, alive, 944 days	469.7
TCGA-BG-A0MK-01A	52 years, female, black or african american, stage:Stage IIB, dead, 1317 days	468.3
TCGA-EO-A3KW-01A	72 years, female, stage:Stage IA, alive, 497 days	456.9
TCGA-SL-A6J9-01A	73 years, female, black or african american, stage:Stage IB, alive, 2 days	453.8
TCGA-EY-A2OO-01A	56 years, female, white, stage:Stage IB, alive, 1392 days	440.8
TCGA-KP-A3W3-01A	72 years, female, white, stage:Stage IB, alive, 794 days	430.0
TCGA-A5-A2K2-01A	77 years, female, white, stage:Stage IA, alive, 3595 days	406.2
TCGA-EO-A3AY-01A	58 years, female, stage:Stage IB, alive, 1158 days	403.4
TCGA-KP-A3W1-01A	76 years, female, stage:Stage IA, alive, 288 days	389.5
TCGA-AP-A3K1-01A	56 years, female, white, stage:Stage IVB, dead, 666 days	378.1
TCGA-AJ-A3BD-01A	57 years, female, white, stage:Stage IIIC, alive, 1039 days	370.8
TCGA-AX-A3FX-01A	69 years, female, white, stage:Stage IIB, dead, 1333 days	370.7
TCGA-SJ-A6ZI-01A	64 years, female, black or african american, stage:Stage IB, alive, 631 days	332.9
TCGA-EO-A3AV-01A	51 years, female, stage:Stage IIIC, alive, 1069 days	282.4
TCGA-A5-A7WK-01A	71 years, female, black or african american, stage:Stage IA, alive, 560 days	231.3
TCGA-EO-A3AS-01A	86 years, female, stage:Stage IA, alive, 1046 days	215.6
TCGA-AX-A05W-01A	60 years, female, white, stage:Stage IIB, alive, 2450 days	172.4
TCGA-FI-A2EY-01A	63 years, female, white, stage:Stage IIIA, dead, 880 days	170.0
TCGA-AJ-A3IA-01A	77 years, female, white, stage:Stage IB, alive, 633 days	153.0
TCGA-FI-A3PX-01A	57 years, female, white, stage:Stage IIIC, alive, 2384 days	127.9
Show allShow less

ENDOMETRIOID ADENOCARCINOMA - Protein relative expression (CPTAC)

Number of samples

153

Samples

Sample ID	Sample type	nRPX
CPT0022530003	Tumor	0.6
CPT0010260003	Tumor	0.5
CPT0020530003	Tumor	0.5
CPT0018790003	Tumor	0.4
CPT0075900003	Tumor	0.4
CPT0024130003	Tumor	0.4
CPT0073520003	Tumor	0.4
CPT0016940003	Tumor	0.4
CPT0007600003	Tumor	0.4
CPT0002430011	Tumor	0.3
CPT0116550004	Tumor	0.3
CPT0026030004	Tumor	0.3
CPT0062940003	Tumor	0.3
CPT0011000003	Tumor	0.3
CPT0070260003	Tumor	0.3
CPT0002500011	Tumor	0.3
CPT0001460012	Tumor	0.3
CPT0001420009	Tumor	0.3
NX18	Normal	0.3
CPT0002210011	Tumor	0.3
CPT0027650003	Tumor	0.2
CPT0063250003	Tumor	0.2
CPT0010820003	Tumor	0.2
CPT0063090003	Tumor	0.2
CPT0113690003	Tumor	0.2
CPT0116630003	Tumor	0.2
NX13	Normal	0.2
CPT0064290004	Tumor	0.2
NX11	Normal	0.2
CPT0001300009	Tumor	0.2
CPT0063890003	Tumor	0.2
CPT0016220003	Tumor	0.2
NX15	Normal	0.2
CPT0026270003	Tumor	0.2
CPT0015520003	Tumor	0.2
CPT0097010003	Tumor	0.1
CPT0076680003	Tumor	0.1
CPT0066620003	Tumor	0.1
NX12	Normal	0.1
CPT0070380004	Tumor	0.1
CPT0000730011	Tumor	0.1
CPT0076860003	Tumor	0.1
CPT0002080011	Tumor	0.1
CPT0023630003	Tumor	0.1
CPT0064210003	Tumor	0.1
CPT0019840003	Tumor	0.1
CPT0027810003	Tumor	0.1
CPT0018960003	Tumor	0.1
CPT0010430003	Tumor	0.1
NX14	Normal	0.1
CPT0075380003	Tumor	0.1
CPT0027320003	Tumor	0.1
CPT0010610003	Tumor	0.1
CPT0027420003	Tumor	0.1
CPT0001850012	Tumor	0.1
CPT0063380003	Tumor	0.1
NX16	Normal	0.1
CPT0002010011	Tumor	0.1
CPT0063670003	Tumor	0.1
CPT0063790003	Tumor	0.0
CPT0097710003	Tumor	0.0
CPT0026430003	Tumor	0.0
CPT0027970003	Tumor	0.0
CPT0009980003	Tumor	0.0
CPT0093280003	Tumor	0.0
CPT0080980003	Tumor	0.0
CPT0023810003	Tumor	0.0
CPT0080300003	Tumor	0.0
CPT0076160003	Tumor	0.0
CPT0080030003	Tumor	0.0
CPT0001910016	Tumor	0.0
CPT0073730003	Tumor	0.0
CPT0027430001	Normal	0.0
CPT0080890001	Normal	0.0
CPT0017870003	Tumor	0.0
CPT0079650003	Tumor	0.0
NX8	Normal	0.0
CPT0021650003	Tumor	0.0
CPT0077650003	Tumor	0.0
CPT0027520003	Tumor	0.0
CPT0027120003	Tumor	0.0
CPT0064930004	Tumor	0.0
CPT0002630003	Tumor	0.0
CPT0016490003	Tumor	0.0
CPT0001140003	Tumor	0.0
CPT0002130003	Tumor	-0.1
CPT0080610003	Tumor	-0.1
CPT0077770003	Tumor	-0.1
CPT0026530003	Tumor	-0.1
CPT0016370003	Tumor	-0.1
NX17	Normal	-0.1
CPT0075940001	Normal	-0.1
CPT0080990001	Normal	-0.1
CPT0078320004	Tumor	-0.1
CPT0022830003	Tumor	-0.1
CPT0064950001	Normal	-0.1
CPT0011020003	Normal	-0.1
NX10	Normal	-0.1
CPT0007100003	Tumor	-0.1
NX6	Normal	-0.1
CPT0063900001	Normal	-0.1
CPT0002450001	Normal	-0.1
CPT0078360001	Normal	-0.1
CPT0018570003	Tumor	-0.1
CPT0016260003	Tumor	-0.1
CPT0064150004	Tumor	-0.1
CPT0026650003	Tumor	-0.1
CPT0001470001	Normal	-0.1
CPT0026780001	Normal	-0.1
CPT0026660001	Normal	-0.1
CPT0007660001	Normal	-0.1
CPT0078610003	Tumor	-0.1
CPT0027130001	Normal	-0.1
CPT0026540001	Normal	-0.2
CPT0022620003	Tumor	-0.2
CPT0073450003	Tumor	-0.2
CPT0063110001	Normal	-0.2
CPT0076500003	Tumor	-0.2
CPT0027020001	Normal	-0.2
CPT0022850001	Normal	-0.2
NX9	Normal	-0.2
CPT0116570003	Normal	-0.2
NX4	Normal	-0.2
CPT0016530001	Normal	-0.2
CPT0016830003	Tumor	-0.2
NX5	Normal	-0.2
CPT0064320001	Normal	-0.2
CPT0073530001	Normal	-0.2
CPT0077780001	Normal	-0.2
CPT0000980012	Tumor	-0.2
CPT0023640001	Normal	-0.2
CPT0080620001	Normal	-0.2
CPT0078710004	Tumor	-0.2
CPT0026770003	Tumor	-0.2
NX1	Normal	-0.2
CPT0070330004	Tumor	-0.2
CPT0017930001	Normal	-0.2
CPT0080400003	Tumor	-0.2
CPT0077660001	Normal	-0.3
CPT0064240001	Normal	-0.3
NX2	Normal	-0.3
NX7	Normal	-0.3
CPT0073460001	Normal	-0.3
CPT0063260001	Normal	-0.4
NX3	Normal	-0.4
CPT0080880003	Tumor	-0.4
CPT0002560003	Tumor	-0.4
CPT0080700003	Tumor	-0.4
CPT0093290000	Normal	-0.5
CPT0079570003	Tumor	N/A
CPT0078880003	Tumor	N/A
CPT0097730003	Tumor	N/A
CPT0000820012	Tumor	N/A
Show allShow less

UTERINE CORPUS ENDOMETRIAL CARCINOMA - Protein relative expression (CPTAC)

Number of samples

160

Samples

Sample ID	Sample type	nRPX
CPT0114100003	Tumor	0.6
CPT0188710003	Tumor	0.5
CPT0134500003	Tumor	0.4
CPT0188100004	Tumor	0.4
CPT0091720003	Tumor	0.3
CPT0186010004	Tumor	0.3
CPT0133600003	Tumor	0.3
CPT0117440003	Tumor	0.3
CPT0247910003	Tumor	0.3
CPT0186560008	Tumor	0.3
CPT0265110003	Tumor	0.3
CPT0133400008	Tumor	0.3
CPT0181670008	Tumor	0.3
CPT0188190004	Tumor	0.3
CPT0136280003	Tumor	0.3
CPT0099050003	Tumor	0.3
CPT0182150003	Tumor	0.3
CPT0117230003	Tumor	0.3
CPT0226860003	Tumor	0.2
CPT0186720008	Tumor	0.2
CPT0188030003	Tumor	0.2
CPT0127980003	Tumor	0.2
CPT0182340004	Tumor	0.2
CPT0188370003	Tumor	0.2
CPT0159110003	Tumor	0.2
CPT0092460003	Tumor	0.2
CPT0244470003.1	Tumor	0.2
CPT0117300003	Tumor	0.2
CPT0117510003	Tumor	0.2
CPT0188270004	Tumor	0.2
CPT0091990003	Tumor	0.2
CPT0186900008	Tumor	0.2
CPT0092860003	Tumor	0.2
CPT0133770008	Tumor	0.2
CPT0288830003	Tumor	0.2
CPT0115470003	Tumor	0.1
CPT0181750004	Tumor	0.1
CPT0095190003	Tumor	0.1
CPT0129080003	Tumor	0.1
CPT0111880003	Tumor	0.1
CPT0172200008	Tumor	0.1
CPT0181960004	Tumor	0.1
CPT0128770003	Tumor	0.1
CPT0127610003	Tumor	0.1
CPT0225010003	Tumor	0.1
CPT0091780003	Tumor	0.1
CPT0248000003	Tumor	0.1
CPT0095100003	Tumor	0.1
CPT0182210004	Tumor	0.1
CPT0088140003	Tumor	0.1
CPT0182070004	Tumor	0.1
CPT0114340003	Tumor	0.1
CPT0247940003	Tumor	0.1
CPT0129640003	Tumor	0.1
CPT0104820003	Tumor	0.1
CPT0128610003	Tumor	0.1
CPT0086090003	Tumor	0.1
CPT0137140008	Tumor	0.1
CPT0181810004	Tumor	0.1
CPT0087260003	Tumor	0.1
CPT0159220008	Tumor	0.1
CPT0182020004	Tumor	0.1
CPT0091910003	Tumor	0.1
NX027	Normal	0.1
CPT0187960004	Tumor	0.1
CPT0116010004	Tumor	0.1
CPT0098920003	Tumor	0.0
CPT0188480004	Tumor	0.0
CPT0234080003	Tumor	0.0
CPT0247880003	Tumor	0.0
CPT0244510003	Tumor	0.0
CPT0100010003	Tumor	0.0
CPT0181610003	Tumor	0.0
CPT0113910003	Tumor	0.0
CPT0093170003	Tumor	0.0
CPT0113430004	Tumor	0.0
CPT0097440003	Tumor	0.0
CPT0203150008	Tumor	0.0
CPT0128370003	Tumor	0.0
CPT0097300003	Tumor	0.0
CPT0226810003	Tumor	0.0
CPT0112780003	Tumor	0.0
CPT0128960003	Tumor	0.0
CPT0111950003	Tumor	0.0
CPT0111720003	Tumor	0.0
CPT0158520008	Tumor	0.0
CPT0100100003	Tumor	0.0
CPT0182380004	Tumor	0.0
CPT0116710003	Tumor	0.0
NX033	Normal	0.0
CPT0096010003	Tumor	0.0
CPT0117560003	Tumor	0.0
CPT0117370004	Tumor	0.0
CPT0095280003	Tumor	-0.1
CPT0181320003	Tumor	-0.1
CPT0127700003	Tumor	-0.1
CPT0116250004	Tumor	-0.1
NX028	Normal	-0.1
CPT0161590008	Tumor	-0.1
CPT0188610003	Tumor	-0.1
NX023	Normal	-0.1
CPT0113060003	Tumor	-0.1
CPT0203040008	Tumor	-0.1
CPT0129520003	Tumor	-0.1
CPT0275270003.1	Tumor	-0.1
CPT0116940003	Tumor	-0.1
CPT0089600003	Tumor	-0.1
CPT0099910003	Tumor	-0.1
CPT0196790004	Tumor	-0.1
NX037	Normal	-0.1
CPT0095880003	Tumor	-0.1
CPT0098270003	Tumor	-0.1
CPT0113330003	Tumor	-0.1
CPT0113850003	Tumor	-0.1
CPT0288750003	Tumor	-0.1
CPT0197250003	Tumor	-0.1
NX029	Normal	-0.1
CPT0083580003	Tumor	-0.1
CPT0190700008	Tumor	-0.2
CPT0092690003	Tumor	-0.2
CPT0111810003	Tumor	-0.2
CPT0086490003	Tumor	-0.2
CPT0112910003	Tumor	-0.2
CPT0134310008	Tumor	-0.2
NX032	Normal	-0.2
CPT0116340004	Tumor	-0.2
NX025	Normal	-0.2
CPT0104690003	Tumor	-0.2
NX035	Normal	-0.2
CPT0182290003	Tumor	-0.2
CPT0116140004	Tumor	-0.2
CPT0211120004	Tumor	-0.2
NX030	Normal	-0.2
CPT0265300003	Tumor	-0.2
NX034	Normal	-0.2
NX020	Normal	-0.3
CPT0172460008	Tumor	-0.3
NX021	Normal	-0.3
CPT0108750003	Tumor	-0.3
CPT0181540008	Tumor	-0.3
CPT0117010004	Tumor	-0.3
CPT0203250008	Tumor	-0.3
CPT0247970003	Tumor	-0.3
NX031	Normal	-0.3
CPT0095230003	Tumor	-0.3
NX022	Normal	-0.3
CPT0115000004	Tumor	-0.3
NX019	Normal	-0.3
CPT0095130004	Tumor	-0.3
NX024	Normal	-0.4
CPT0126000003	Tumor	-0.4
CPT0171090008	Tumor	-0.4
NX036	Normal	-0.4
CPT0238260003	Tumor	-0.4
NX038	Normal	-0.4
CPT0174890008	Tumor	-0.4
CPT0115530003	Tumor	-0.4
NX026	Normal	-0.4
CPT0244470003	Tumor	N/A
CPT0275270003	Tumor	N/A
Show allShow less

ENDOMETRIAL CANCER - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA000857
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Adenocarcinoma, NOS
Neoplasm, malignant, NOS